ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $193,791 | -18.5% | 35,558 | +0.4% | 0.00% | -100.0% |
| Q2 2023 | $237,722 | -24.0% | 35,428 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $312,829 | +15.6% | 35,428 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $270,670 | +7.4% | 35,428 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $252,000 | -12.2% | 35,428 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $287,000 | -85.4% | 35,428 | -75.0% | 0.00% | -75.0% |
| Q1 2022 | $1,964,000 | -50.5% | 141,484 | +0.2% | 0.00% | -42.9% |
| Q4 2021 | $3,964,000 | -16.8% | 141,268 | +0.8% | 0.01% | -22.2% |
| Q3 2021 | $4,765,000 | -16.5% | 140,202 | +0.3% | 0.01% | -18.2% |
| Q2 2021 | $5,709,000 | +66.4% | 139,730 | +63.9% | 0.01% | +57.1% |
| Q1 2021 | $3,431,000 | -31.1% | 85,231 | +1.1% | 0.01% | -30.0% |
| Q4 2020 | $4,983,000 | +23.7% | 84,271 | +1.7% | 0.01% | +11.1% |
| Q3 2020 | $4,028,000 | +3.0% | 82,826 | +2.4% | 0.01% | -10.0% |
| Q2 2020 | $3,912,000 | +154.5% | 80,866 | +46.2% | 0.01% | +100.0% |
| Q1 2020 | $1,537,000 | – | 55,311 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |